Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
Clinical trial NCT03425539 · COMPLETED
Trial details
- NCT number
- NCT03425539
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-21
- Primary completion
- 2021-08-17
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.